Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat/Phentermine vs Placebo/Phentermine for Weight Loss and Vascular Function in Overweight Patients with Back Pain
NCT03675191Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Oct 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in obesity comparing Orlistat + Phentermine with Placebo + Phentermine (2 arms). Primary endpoints: Body mass index changes at 12 weeks and Vascular function changes at 12 weeks. Started Oct 2018; status: completed.
02
Drugs
orlistat
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03675191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03675191.